These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30578034)

  • 1. Cyclic tripeptide-based potent human SIRT7 inhibitors.
    Li S; Wu B; Zheng W
    Bioorg Med Chem Lett; 2019 Feb; 29(3):461-465. PubMed ID: 30578034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic Tripeptide-based Potent and Selective Human SIRT5 Inhibitors.
    Jiang Y; Zheng W
    Med Chem; 2020; 16(3):358-367. PubMed ID: 31161996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic peptide-based potent human SIRT6 inhibitors.
    Liu J; Zheng W
    Org Biomol Chem; 2016 Jul; 14(25):5928-35. PubMed ID: 27248480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
    Huang Y; Liu J; Yan L; Zheng W
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1612-1617. PubMed ID: 26874402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.
    Olsen CA; Ghadiri MR
    J Med Chem; 2009 Dec; 52(23):7836-46. PubMed ID: 19705846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight.
    Rajabi N; Auth M; Troelsen KR; Pannek M; Bhatt DP; Fontenas M; Hirschey MD; Steegborn C; Madsen AS; Olsen CA
    Angew Chem Int Ed Engl; 2017 Nov; 56(47):14836-14841. PubMed ID: 29044784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of mono and bicyclic tetrapeptides thioester as potent inhibitor of histone deacetylases.
    Hoque MA; Islam MS; Islam MN; Kato T; Nishino N; Ito A; Yoshida M
    Amino Acids; 2014 Oct; 46(10):2435-44. PubMed ID: 25048030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).
    Huber K; Schemies J; Uciechowska U; Wagner JM; Rumpf T; Lewrick F; Süss R; Sippl W; Jung M; Bracher F
    J Med Chem; 2010 Feb; 53(3):1383-6. PubMed ID: 20030343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.
    You W; Steegborn C
    J Med Chem; 2018 Dec; 61(23):10922-10928. PubMed ID: 30395713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases.
    Hoque MA; Arai T; Nishino N; Kim HJ; Ito A; Yoshida M
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6770-2. PubMed ID: 23021104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic tetrapeptides as potent HDAC inhibitors: effect of aliphatic loop position and hydrophobicity on inhibitory activity.
    Islam MN; Islam MS; Hoque MA; Kato T; Nishino N; Ito A; Yoshida M
    Bioorg Med Chem; 2014 Aug; 22(15):3862-70. PubMed ID: 25022972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
    Sun W; Chen X; Huang S; Li W; Tian C; Yang S; Li L
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127215. PubMed ID: 32631504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Selective Cyclic Peptidic Human SIRT5 Inhibitor.
    Liu J; Huang Y; Zheng W
    Molecules; 2016 Sep; 21(9):. PubMed ID: 27626398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalent SIRT1 inhibitors.
    Wang J; Zang W; Liu J; Zheng W
    Bioorg Med Chem Lett; 2017 Jan; 27(2):180-186. PubMed ID: 27964881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand.
    Nishino N; Yoshikawa D; Watanabe LA; Kato T; Jose B; Komatsu Y; Sumida Y; Yoshida M
    Bioorg Med Chem Lett; 2004 May; 14(10):2427-31. PubMed ID: 15109626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.
    Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB
    Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(I)-Mediated Denitrogenative Macrocyclization for the Synthesis of Cyclic α
    Chen CC; Wang SF; Su YY; Lin YA; Lin PC
    Chem Asian J; 2017 Jun; 12(12):1326-1337. PubMed ID: 28395122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.
    McCarthy AR; Pirrie L; Hollick JJ; Ronseaux S; Campbell J; Higgins M; Staples OD; Tran F; Slawin AM; Lain S; Westwood NJ
    Bioorg Med Chem; 2012 Mar; 20(5):1779-93. PubMed ID: 22304848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
    Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
    J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.